Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction. Indian Heart J (2016) 0.79

Platelet to lymphocyte ratio in the prediction of adverse outcomes after acute coronary syndrome: a meta-analysis. Sci Rep (2017) 0.75

Usefulness of the platelet-to-lymphocyte ratio in predicting long-term cardiovascular mortality in patients with peripheral arterial occlusive disease. Postepy Kardiol Interwencyjnej (2017) 0.75

Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio, Mean Platelet Volume and Red Cell Distribution Width Measures in Bells Palsy. Open Access Maced J Med Sci (2017) 0.75

Prognostic Value of Circulating Inflammatory Cells in Patients with Stable and Acute Coronary Artery Disease. Front Cardiovasc Med (2017) 0.75

Third universal definition of myocardial infarction. Circulation (2012) 8.47

Platelets in inflammation and atherogenesis. J Clin Invest (2005) 4.10

Myocardial no-reflow in humans. J Am Coll Cardiol (2009) 3.71

No-reflow phenomenon. Circulation (2002) 2.30

Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology (2014) 2.08

Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation (2004) 2.06

Role of blood platelets in infection and inflammation. J Interferon Cytokine Res (2002) 2.01

Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers (2012) 2.00

Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol (1998) 1.95

Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction. Am J Cardiol (2014) 1.59

Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis (2012) 1.43

Mean platelet volume predicts left descending artery occlusion in patients with non-ST-elevation myocardial infarction. Platelets (2013) 1.41

Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. Am J Clin Oncol (2003) 1.32

Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis (2006) 1.30

Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol (2006) 1.26

Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol (2010) 1.24

Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One (2013) 1.15

Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study. Int J Cardiol (2012) 1.11

Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol (1988) 0.98

Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol (2010) 0.96

Association of platelet-monocyte aggregates with platelet activation, systemic inflammation, and myocardial injury in patients with non-st elevation acute coronary syndromes. Clin Cardiol (2007) 0.93

An assessment of neutrophils/lymphocytes ratio in patients suspected of acute coronary syndrome. Arq Bras Cardiol (2008) 0.93

Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit (2014) 0.93

Relation between red cell distribution width and severity of coronary artery disease in patients with acute myocardial infarction. Angiology (2012) 0.91

Mechanical complications after myocardial infarction reliably predicted using C-reactive protein levels and lymphocytopenia. Cardiology (2003) 0.88

Relationship Between Hematologic Indices and Global Registry of Acute Coronary Events Risk Score in Patients With ST-Segment Elevation Myocardial Infarction. Clin Appl Thromb Hemost (2014) 0.84

Usefulness of novel hematologic inflammatory parameters to predict prosthetic mitral valve thrombosis. Am J Cardiol (2013) 0.83

Manual versus nonmanual thrombectomy in primary and rescue percutaneous coronary angioplasty. Heart Vessels (2010) 0.83

Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost (2013) 0.83

The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention. Blood Coagul Fibrinolysis (2014) 0.79